Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Milione

Showing results (111-120 of 206) with videos related to

Pageof 21
Sort By:
Endocrine-Related Cancer|May 12, 2021
Target therapies plus somatostatin analogs in NETs: a network meta-analysisSara Pusceddu, Antonio Facciorusso, Luca Giacomelli, et al.
Advances in Therapy|November 21, 2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary GroupNicola Fazio, Massimo Falconi, Emanuela Foglia, et al.
British Journal of Cancer|May 10, 2024
Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasmsValentina Angerilli, Giovanna Sabella, Michele Simbolo, et al.
Targeted Oncology|August 4, 2018
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy ApproachesDaniela Femia, Natalie Prinzi, Andrea Anichini, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cellsMonica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Targeted Oncology|November 6, 2015
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal CancerFilippo Pietrantonio, Filippo de Braud, Massimo Milione, et al.
Neuroendocrinology|March 5, 2016
The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic CategoriesMassimo Milione, Patrick Maisonneuve, Francesca Spada, et al.
Tumori|May 20, 2022
Metastatic pheochromocytomas and paragangliomas: where are we?Natalie Prinzi, Francesca Corti, Martina Torchio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2016
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patientsAndrea Sartore-Bianchi, Filippo Pietrantonio, Alessio Amatu, et al.
Cancer Research|July 5, 2015
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor PrognosisGiulia Bertolini, Lucia D'Amico, Massimo Moro, et al.
Pageof 21

Showing results (111-120 of 206) with videos related to

Sort By:
Pageof 21
Endocrine-Related Cancer|May 12, 2021
Target therapies plus somatostatin analogs in NETs: a network meta-analysisSara Pusceddu, Antonio Facciorusso, Luca Giacomelli, et al.
Advances in Therapy|November 21, 2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary GroupNicola Fazio, Massimo Falconi, Emanuela Foglia, et al.
British Journal of Cancer|May 10, 2024
Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasmsValentina Angerilli, Giovanna Sabella, Michele Simbolo, et al.
Targeted Oncology|August 4, 2018
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy ApproachesDaniela Femia, Natalie Prinzi, Andrea Anichini, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cellsMonica Parodi, Giovanni Centonze, Fabio Murianni, et al.
Targeted Oncology|November 6, 2015
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal CancerFilippo Pietrantonio, Filippo de Braud, Massimo Milione, et al.
Neuroendocrinology|March 5, 2016
The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic CategoriesMassimo Milione, Patrick Maisonneuve, Francesca Spada, et al.
Tumori|May 20, 2022
Metastatic pheochromocytomas and paragangliomas: where are we?Natalie Prinzi, Francesca Corti, Martina Torchio, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2016
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patientsAndrea Sartore-Bianchi, Filippo Pietrantonio, Alessio Amatu, et al.
Cancer Research|July 5, 2015
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor PrognosisGiulia Bertolini, Lucia D'Amico, Massimo Moro, et al.
Pageof 21